Technical Articles

Human KRAS G12D & cRAF Binding Kit
KRAS G12D靶点的研究进展与临床意义
Research Progress and Clinical Significance of KRAS G12D Target
发布时间 2026-02-27
The RAS gene family is the most widely mutated oncogene in tumors, accounting for approximately 20% to 30% of all tumor mutations, and includes three subtypes: KRAS, HRAS, and NRAS.
View details
  • Cancer
  • Human KRAS G12D & cRAF Binding Kit
  • Tumor
  • Oncogene
Total 1
  • 1
Go to
UA
Link：
Products
Application
Cell FactorTarget Proteins
Custom Services
Custom Protein Expression ServicesCustom SPR Services
About Us
PromotionTechnical ArticlesProduct ApplicationFAQsCitationsAbout Us
We Media：
Facebook Linkedin YouTube X Thraeds Pinterest
©2021-2026 all rights reserved UA Biotechnology Co.,Ltd.
Privacy Policy
网站备案号 浙ICP备2022019033号-2 浙公网安备33010202004867号
 Business license (three certificates in one)
Tel：+86-25-56221161
E-mail：order@ua-bio.com
All products sold on this website shall not be used for clinical diagnosis or treatment of humans or animals, and shall only be used for non-medical purposes such as industrial or scientific research.